Gene · 51203
Papers1,551
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
61 to 80 of 1,551
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Individualized mRNA Vaccines in Melanoma-Where Do We Stand? | Vaccines (Basel) | 2025 | 41012188 | PubTator, text mining | PubMed |
| Engineering Universal Cancer Immunity: Non-Tumor-Specific mRNA Vaccines Trigger Epitope Spreading in Cold Tumors. | Vaccines (Basel) | 2025 | 41012173 | PubTator, text mining | PubMed |
| Influenza Vaccines: Current Status, Adjuvant Strategies, and Efficacy. | Vaccines (Basel) | 2025 | 41012165 | PubTator, text mining | PubMed |
| Identification of T-Cell Epitopes and Vaccine Development for African Swine Fever Virus. | Vaccines (Basel) | 2025 | 41012158 | PubTator, text mining | PubMed |
| Targeted inhibition of hepatic de novo ceramide synthesis ameliorates MASH. | Sci Adv | 2025 | 41004573 | PubTator, text mining | PubMed |
| Emerging Strategies for Cargo Loading and Engineering of Extracellular Vesicles for Breast Cancer Treatment. | Nanomaterials (Basel) | 2025 | 41003053 | PubTator, text mining | PubMed |
| Bench to Bedside Modeling of mRNA Encoding IgG Using a Multiscale Mechanistic Pharmacokinetic-Toxicokinetic (PK-TK) Model: A Case Study With Anti-Claudin 18.2. | Clin Transl Sci | 2025 | 40977574 | PubTator, text mining | PubMed |
| mRNA-encoded mutant HPV16/18 vaccines promote specific T-cell responses and synergize with anti-PD-1 checkpoint blockade in mediating therapeutic tumor regression in mice. | J Immunother Cancer | 2025 | 40967673 | PubTator, text mining | PubMed |
| Novel TNF-α-targeting mRNA therapy for sustained psoriasis treatment and relapse prevention by suppressing IL-15-TRM signaling. | J Control Release | 2025 | 40935068 | PubTator, text mining | PubMed |
| NuSAP1 promotes bipolar spindle assembly in Trypanosoma brucei by bundling spindle microtubules. | bioRxiv | 2025 | 40909470 | PubTator, text mining | PubMed |
| Bridging the gap of late-gestation nephrogenesis using a non-human primate model. | bioRxiv | 2025 | 40894529 | PubTator, text mining | PubMed |
| Preliminary study on SIRI dynamic changes for the efficacy prediction and prognosis evaluation of advanced cancer patients treated with immunotherapy. | Discov Oncol | 2025 | 40892139 | PubTator, text mining | PubMed |
| Harnessing the Loop: The Perspective of Circular RNA in Modern Therapeutics. | Vaccines (Basel) | 2025 | 40872908 | PubTator, text mining | PubMed |
| Chemically modified tRNA enhances the translation capacity of mRNA rich in cognate codons. | Nat Commun | 2025 | 40846860 | PubTator, text mining | PubMed |
| To modify or not to modify-That is still the question for some mRNA applications. | Mol Ther Nucleic Acids | 2025 | 40832630 | PubTator, text mining | PubMed |
| Stabilization of norovirus GII.3 virus-like particles by rational disulfide engineering. | NPJ Vaccines | 2025 | 40830611 | PubTator, text mining | PubMed |
| Delivering the Message: Translating mRNA Therapy for Liver Inherited Metabolic Diseases. | J Inherit Metab Dis | 2025 | 40826824 | PubTator, text mining | PubMed |
| Identification of biomarkers and potential therapeutic targets of breast cancer using bioinformatics analysis. | Medicine (Baltimore) | 2025 | 40826700 | PubTator, text mining | PubMed |
| Mechanistic insights into circularization via Anabaena group I intron-based scarless circular RNA. | Mol Ther Nucleic Acids | 2025 | 40822029 | PubTator, text mining | PubMed |
| TRIP13-induced NUSAP1 upregulation promotes CcRCC progression through EMT and PI3K/AKT/mTOR pathway. | J Transl Med | 2025 | 40790482 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/51203/papers?page=4